Navigation Links
Controversy: Malaria Vaccine - Future Possibility Or Just A Dream?

While scientists world over have hailed the results of a trial of a malaria vaccine by pharmaceutical company GlaxoSmithKline (GSK), that has halved the incidence of severe disease in children, Pierre Druilhi, a French // entist, warned that malaria vaccination is still a far off dream failing better international coordination.

Shunning claims of a medical breakthrough, Pierre Druilhi, director of the Biomedical Parasitological Unit at the Pasteur Institute in Paris said that it is too early to say we have a vaccine against malaria. He presented his speech at the fourth annual pan-African malaria conference, organized by the Multilateral Initiative on Malaria, (MIM), held in the Cameroonian capital Yaounde.

GSK presented trials of the RTS S/AS02A vaccine carried out on 1,442 children between one and four years of age in Mozambique in 2003. A six-month follow up study and another 12 months later Early trials of the vaccine last year showed it was effective over six months. The new study of the children who have been followed up for 18 months, published online in the journal Lancet, revealed that the protection was maintained, with a 30 % reduced risk of clinical malaria.

GSK worked with CISM, the Hospital Clinic of the University of Barcelona, the Ministry of Health in Mozambique and the Malaria Vaccine Initiative to develop the vaccine.

Pedro Alonso, scientific director of the Manhica Health Research Centre (CISM), said that 'The unprecedented results in this study is further evidence that an effective vaccine to help control the malaria pandemic, which kills more than one million people in developing countries, is very possible'.

While researchers have accepted that, at least for the foreseeable future, there is no prospect of a vaccine, which could wipe out malaria or even provide lifelong immunity, a vaccine that would turn the disease into a mostly mild infection would play an important role in the eff
'"/>




Page: 1 2

Related medicine news :

1. Malaria strikes Munger tribals
2. Sponging Cattle betters spraying in eradicating Malaria
3. Gene researchers make Malaria-resistant mosquito
4. More Treatment Options For Malaria
5. Scientists Unveil Mechanism Behind Resistance to Severe Malaria
6. Jharkhand reports 13,000 Malaria cases
7. Researchers Discover Protein That Causes Malaria
8. Malarial gene ascertained
9. Artesunate Is Better For Malaria Than Quinine
10. New Strategies For Effective Treatment Of Malaria
11. Chloroquine and Primaquine combination Malarial drug for resistant parasites.
Post Your Comments:
(Date:12/2/2008)... , National Non-profit La...that Provides Eye Exams at No Cost to Eligible Pat... San Francisco, CA (Vocus) December 2...eniors who suffer with an eye disease known as Age...always, "No.", , , , ,Picture this&hell...
(Date:12/2/2008)... , Liberty Mutual Provide...ms at www.BeFireSmart.com , ...ty Mutual Insurance and Holly Robinson Peete , a...ming up to encourage families to set aside a few m...ty precautions and response plans at BeFireSmart.c...
(Date:12/1/2008)... SOUTH BEND, Ind., Dec. 2 Patient...cilities are on the rise according to a new report...atient Pulse Report: Patient,Perspectives on Amer...,facilities as a driver for improvement in patien...ore than 2 million patients treated at more than,...
(Date:12/1/2008)... , CHICAGO New research has found that the avail...phy (CT) scanner in an emergency room can signific...ceive a potentially life-saving treatment. Results...nter (NSMC)-Salem Hospital in Salem, Mass., will b...iological Society of North America (RSNA). , "T...
Breaking Medicine News(10 mins):Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 2Health News:This Holiday Season EyeCare America Asks Seniors, 'Do you see what I see?' 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 2Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 3Health News:Liberty Mutual and Holly Robinson Peete Team Up to Remind Families to Be Fire Smart this Holiday Season with Tips on Fire Safety 4Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2
...udy shows the anti-inflammatory drug naproxen may ...a non-steroidal anti-inflammatory drug (NSAID) com...y and arthritic conditions. Researchers in Quebec ...Ds //in the prevention of acute myocardial infarct...
...cessfully used gene therapy to restore sight to an...eam of scientists led by Jean Bennett, at the Univ...this month's Nature Genetics.Their experiment invo...a form of blindness, that also affects human infan...
...hicago, studied the use of a ginseng extract for t...een shown to have many beneficial effects on healt...he condition affects about 8% of the U.S. populati...he vast majority of people with diabetes more than...
...t that acupuncture is at least as safe as conventi...n the safety of complementary and alternative medi... one of the first serious safety assessments on ac...d physiotherapists carrying out acupuncture agreed...
Other Medicine News:
(Date:12/1/2008)...Dec. 1 Genaera Corporat...of subjects has begun in study MSI-1436C-102 (Stud... of trodusquemine (MSI-1436) in overweight and obe...ic for the treatment of type 2 diabetes and obesit...te insulin and leptin pathways through the highly ...
(Date:11/30/2008)...c. 1 Older adults who e...ow and a greater number of small blood vessels in ...t the annual meeting of the Radiological Society o...ducted at the University of North Carolina ( UNC...ans of older adults who exercise to brain scans of...
(Date:11/26/2008)...26 Children whose eyes ...tly increased risk of developing mental illness by... Clinic study published this month in Pediatrics ,...ediatrics. , , The retrospective study exam...bismus (misaligned eyes) and compared them with re...
(Date:11/25/2008)...pondents against expanding statin use broadly in w..., N.J., Nov. 25 JUPITER, a clinica...iovascular risk of healthy patients with elevated ...er adults, according to a national poll directed a...ok part in the online poll conducted by medical ne...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Exercise Helps Prevent Age-Related Brain Changes in Older Adults 2Exercise Helps Prevent Age-Related Brain Changes in Older Adults 3Eye Divergence in Children Triples Risk of Mental Illness 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 2Dramatic JUPITER Findings Fail to Sway Prescribing Behavior, Poll Shows 3Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 1Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 2Dallas Among the First to Offer Probiotic Supplement Align 28R 29 6984 3VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 1VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 2VH1 Teams Up with Dr Drew for Celebrity Rehab With Dr Drew a Series Depicting the Process of Overcoming Addiction 6979 3A young star in childhood cancer research 6974 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 2
...07 – On 23 July SYGNIS Pharma,AG will presen...AX200 (AXIS-study)., AX200, a compound for the tre...ate in SYGNIS’ product pipeline. The,primary...ty of,AX200 in acute stroke patients. The results ...ion for the further clinical,development of AX200....
...swire-FirstCall/ -- ImClone,Systems Incorporated a...sults from an open-label Phase III study of ERBITU...the first-line,treatment for metastatic non-small ...ts primary endpoint of progression-free,survival (...w,committee (IRRC). However, key secondary endpoin...
Other Medicine Technology:Sygnis Pharma AG announces date for presentation of clinical,results 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 2Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 3Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 4Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 5Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 6Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 7Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 8Data Available From Erbitux Phase III Study in First-Line Treatment,of Advanced Lung Cancer 9
Solid 8 mm blades. Dull finish. Most popular size or model.
Open 10 mm blades. Dull finish.
Open 14 mm blades of heavy 1 mm wire. Dull finish. Most popular size or model.
Fenestrated 14 mm blades. Self-locking mechanism. Dull finish.
Medicine Products: